AIM
ZBH icon

Artemis Investment Management’s Zimmer Biomet ZBH Stock Holding History

Artemis Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-138,233
Closed -$20.1M – 235
2023
Q2 		$20.1M Sell
138,233
-30,880
-18% -$4.2M 0.25% 103
2023
Q1 		$21.8M Sell
169,113
-14,833
-8% -$1.86M 0.27% 109
2022
Q4 		$23.5M Buy
+183,946
New +$21.3M 0.27% 102
2017
Q2 		– Sell
-119,301
Closed -$14.1M – 253
2017
Q1 		$14.1M Sell
119,301
-10,411
-8% -$1.18M 0.38% 67
2016
Q4 		$13M Buy
+129,712
New +$13.9M 0.35% 72

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artemis Investment Management's ZBH Position: Q3 2023 in Review

Artemis Investment Management sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 138,233 shares — an estimated $20.1M sold.

Artemis Investment Management first reported a position in ZBH in Q4 2016 and held it in 5 quarters. The position peaked at $23.5M in Q4 2022. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

  • Artemis Investment Management reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
  • Artemis Investment Management sold 138,233 Zimmer Biomet shares in Q3 2023, an estimated $20.1M.
  • Artemis Investment Management first reported a position in Zimmer Biomet in Q4 2016 and held it in 5 quarters.
  • Artemis Investment Management's Zimmer Biomet position peaked at $23.5M in Q4 2022.
  • 1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Artemis Investment Management's 13F filing for Q3 2023, filed 16 Oct 2023.